This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Resumen de acción DP80
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body’s ability to deliver oxygen.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Diffusion Pharmaceuticals Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.97 |
| 52 Week High | US$15.08 |
| 52 Week Low | US$5.67 |
| Beta | 1.76 |
| 1 Month Change | 31.11% |
| 3 Month Change | 0% |
| 1 Year Change | -47.16% |
| 3 Year Change | -92.47% |
| 5 Year Change | n/a |
| Change since IPO | -76.24% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| DP80 | DE Biotechs | Mercado DE | |
|---|---|---|---|
| 7D | 12.7% | -4.9% | -1.5% |
| 1Y | -47.2% | -19.9% | 0.9% |
Rentabilidad vs. Industria: DP80 underperformed the German Biotechs industry which returned -9.3% over the past year.
Rentabilidad vs. Mercado: DP80 underperformed the German Market which returned 2.1% over the past year.
Volatilidad de los precios
| DP80 volatility | |
|---|---|
| DP80 Average Weekly Movement | 7.3% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: DP80's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: DP80's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2001 | 13 | Bob Cobuzzi | www.diffusionpharma.com |
Resumen de fundamentos de Diffusion Pharmaceuticals Inc.
| Estadísticas fundamentales de DP80 | |
|---|---|
| Capitalización bursátil | €14.24m |
| Beneficios(TTM) | -€12.03m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-1.2x
Ratio precio-beneficio (PE)¿Está DP80 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DP80 | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$13.08m |
| Beneficios | -US$13.08m |
Últimos beneficios comunicados
Jun 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -6.41 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado DP80 a largo plazo?
Ver rendimiento histórico y comparativa